Greenwich LifeSciences
GLSI • NASDAQ
Greenwich LifeSciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Snehal S. Patel, with a market cap of $357.7M.
Market Cap$357.7M
Employees6.0
CEOSnehal S. Patel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 19, 2026 · in a monthQ1 2026
Financials
Greenwich LifeSciences FAQ
Common questions about Greenwich LifeSciences
Greenwich LifeSciences is scheduled to report earnings for Q1 2026 on May 19, 2026.
Greenwich LifeSciences has approximately 6 employees.